Editorial [Hot Topic: Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia (Executive Editors: Francis J. Giles / Maher Albitar)]

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|5|7|607-607

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.5, Iss.7, 2005-11, pp. : 607-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 653-661

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Mammalian Target of Rapamycin in Atherosclerosis

By  

Current Molecular Medicine, Vol. 18, Iss. 4, 2018-05 ,pp. : 216-232

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: The Adenosinergic System - From Physiology to Pathology and Therapeutics (Guest Editors: A. Rees and J. Ham)]

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 4, 2007-08 ,pp. : 264-264

Bentham Science Publishers

Access to resources Recommend Favorite

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

By Decker Thomas  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

Editorial [Hot Topic: The RB-Pathway in Cancer (Executive Editor: Erik Knudsen)]

By  

Current Molecular Medicine, Vol. 6, Iss. 7, 2006-11 ,pp. : 703-704

Bentham Science Publishers

Access to resources Recommend Favorite